iRhythm Technologies, Inc. (IRTC)

Market Cap	5.90B
Revenue (ttm)	702.57M
Net Income (ttm)	-51.46M
Shares Out	32.22M
EPS (ttm)	-1.62
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	108,480
Open	184.81
Previous Close	187.30
Day's Range	180.00 - 184.81
52-Week Range	67.92 - 212.00
Beta	1.10
Analysts	Strong Buy
Price Target	199.79 (+9.18%)
Earnings Date	Oct 30, 2025

About IRTC

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. It also provides Zio Monitor System, a prescription-only remote electrocardiogram (ECG) monitoring system consisting a patch ECG monitor t...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Oct 20, 2016
• Employees: 2,000
• Stock Exchange: NASDAQ
• Ticker Symbol: IRTC
• Website: https://www.irhythmtech.com

Financial Performance

In 2024, iRhythm Technologies's revenue was $591.84 million, an increase of 20.13% compared to the previous year's $492.68 million. Losses were -$113.29 million, -8.20% less than in 2023.

Analyst Summary

According to 14 analysts, the average rating for IRTC stock is "Strong Buy." The 12-month stock price target is $199.79, which is an increase of 9.18% from the latest price.

Price Target

$199.79

(9.18% upside)

Analyst Consensus: Strong Buy